AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2
Recalled August 13, 2025 · FDA recall D-0559-2025 · AEQUITA PHARMACY
Hazard
Lack of Processing Controls. · FDA Class II
Units
143 vials
Sold at
MA
Description
Lack of Processing Controls.
Product
Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Manufacturer(s)
AEQUITA PHARMACY
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →